A retrospective examination of lung cancer incidence among the predominantly Black population in the Southern Community Cohort Study demonstrated a much smaller percentage of Black patients with lung cancer met screening eligibility criteria (32%) compared with White patients (56%). The lower percentage of eligibility was primarily associated with lower pack years [25]. Additionally, the expansion of lung cancer screening guidelines will improve eligibility of women for lung cancer screening compared with men [15]. FDG-PET/CT Skull Base to Mid-Thigh The role of fluorine-18-2-fluoro-2-deoxy-D-glucose (FDG)-PET/CT skull base to mid-thigh as a lung cancer screening modality has not been adequately studied. The body of evidence for this modality is growing but remains limited [26,27]. MRI Chest Without and With IV Contrast The role of MRI, chest without or with IV contrast, as a lung cancer screening modality has not been adequately studied. MRI Chest Without IV Contrast The role of MRI chest without IV contrast as a lung cancer screening modality has not been adequately studied. There is a growing body of evidence suggesting MRI without IV contrast may have a role in screening for lung cancer [28-30]. Radiography Chest Chest radiography screening does not reduce lung cancer mortality in this population [3]. Lung Cancer Screening Variant 2: Lung cancer screening. Patient younger than 50 years of age and 20 or more packs per year history of smoking and one additional risk factor (ie, radon exposure or occupational exposure or cancer history or family history of lung cancer or history of COPD or history of pulmonary fibrosis). Initial imaging. CT Chest With IV Contrast There is no evidence to support screening in this population with chest CT with IV contrast. CT Chest Without and With IV Contrast There is no evidence to support screening in this population with chest CT without and with IV contrast.
Lung Cancer Screening PCAs. A retrospective examination of lung cancer incidence among the predominantly Black population in the Southern Community Cohort Study demonstrated a much smaller percentage of Black patients with lung cancer met screening eligibility criteria (32%) compared with White patients (56%). The lower percentage of eligibility was primarily associated with lower pack years [25]. Additionally, the expansion of lung cancer screening guidelines will improve eligibility of women for lung cancer screening compared with men [15]. FDG-PET/CT Skull Base to Mid-Thigh The role of fluorine-18-2-fluoro-2-deoxy-D-glucose (FDG)-PET/CT skull base to mid-thigh as a lung cancer screening modality has not been adequately studied. The body of evidence for this modality is growing but remains limited [26,27]. MRI Chest Without and With IV Contrast The role of MRI, chest without or with IV contrast, as a lung cancer screening modality has not been adequately studied. MRI Chest Without IV Contrast The role of MRI chest without IV contrast as a lung cancer screening modality has not been adequately studied. There is a growing body of evidence suggesting MRI without IV contrast may have a role in screening for lung cancer [28-30]. Radiography Chest Chest radiography screening does not reduce lung cancer mortality in this population [3]. Lung Cancer Screening Variant 2: Lung cancer screening. Patient younger than 50 years of age and 20 or more packs per year history of smoking and one additional risk factor (ie, radon exposure or occupational exposure or cancer history or family history of lung cancer or history of COPD or history of pulmonary fibrosis). Initial imaging. CT Chest With IV Contrast There is no evidence to support screening in this population with chest CT with IV contrast. CT Chest Without and With IV Contrast There is no evidence to support screening in this population with chest CT without and with IV contrast.